TheraSim develops online clinical simulation tools that predict and prevent performance errors in the application of medical treatment. Its products aim to help healthcare professionals more rapidly assimilate new information and make more effective clinical decisions. The company sells clinical simulation products for use in medical universities, hospitals and in support of clinical trials. Management says the new investment will fuel market expansion of those products. TheraSim reports a current revenue stream which, together with the financing, positions the company for continued growth.

Total raised

$1M

Funding rounds

1

Latest round

Equity

Latest activity

Jan 2010